A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation

British Journal of Haematology

Volumn 138, Issue 1, 2007, Pages 82-93

  Campbell, Robert A ^a   Fischer, Thomas H ^a,b   Wolberg, Alisa S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Fibrin; Fibrinolysis; Haemophilia; Platelet; Recombinant factor VIIa

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; DRUG ACTIVITY; FIBRINOLYSIS; HEMOPHILIA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBIN TIME; THROMBOCYTE;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CELLS, CULTURED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VII; FIBRIN; HEMOPHILIA A; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; PLATELET ACTIVATION; PLATELET ADHESIVENESS; RECOMBINANT PROTEINS; THROMBIN; TISSUE PRESERVATION;

EID: 34250009348     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06617.x     Document Type: Article

References (37)

1. Alberio, L., Safa, O., Clemetson, K.J., Esmon, C.T. Dale, G.L. (2000) Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood, 95, 1694 1702.
2. Allen, G.A., Wolberg, A.S., Oliver, J.A., Hoffman, M., Roberts, H.R. Monroe, D.M. (2004) Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. Journal of Thrombosis and Haemostasis, 2, 402 413.
3. Allen, G.A., Persson, E., Campbell, R.A., Ezban, M., Hedner, U. Wolberg, A.S. (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 683 689.
4. Bode, A.P. Miller, D.T. (1986) Analysis of platelet factor 3 in platelet concentrates stored for transfusion. Vox Sanguinis, 51, 299 305.
5. Bode, A.P. Read, M.S. (2000) Lyophilized platelets: continued development. Transfusion Science, 22, 99 105.
6. Carson, S.D., Ross, S.E., Bach, R. Guha, A. (1987) An inhibitory monoclonal antibody against human tissue factor. Blood, 70, 490 493.
7. Chao, F.C., Kim, B.K., Houranieh, A.M., Liang, F.H., Konrad, M.W., Swisher, S.N. Tullis, J.L. (1996) Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets. Transfusion, 36, 536 542.
8. Darby, S.C., Keeling, D.M., Spooner, R.J., Wan Kan, S., Giangrande, P.L., Collina, P.W., Hill, F.G., Hay, C.R. Organisation, U.H.C.D. (2004) The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. Journal of Thrombosis and Haemostasis, 2, 1047 1054.
9. Fischer, T.H., Merricks, E.P., Russell, K.E., Raymer, R.A., White, G.C., Bode, A.P., Nichols, T.C. Read, M.S. (2000) Intracellular function in rehydrated lyophilized platelets. British Journal of Haematology, 111, 167 174.
10. Fischer, T.H., Merricks, E., Bellinger, D.A., Hayes, P.M., Smith, R.S., Raymer, R.A., Read, M.S., Nichols, T.C. Bode, A.P. (2001) Splenic clearance mechanisms of rehydrated, lyophilized platelets. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 29, 439 451.
11. Fischer, T.H., Merricks, E.P., Bode, A.P., Bellinger, D.A., Russell, K., Reddick, R., Sanders, W.E., Nichols, T.C. Read, M.S. (2002) Thrombus formation with rehydrated, lyophilized platelets. Hematology, 7, 359 369.
12. Gabriel, D.A., Li, X., Monroe, III., D.M., Roberts, H.R. (2004) Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. Journal of Thrombosis and Haemostasis, 2, 1816 1822.
13. Hedner, U. (2000) NovoSeven as a universal haemostatic agent. Blood Coagulation and Fibrinolysis, 11 (Suppl. 1 S107 S111.
14. Henderson, N., Key, N.S., Christie, B., Kisiel, W., Foster, D. Nelsestuen, G.L. (2002) Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome. Thrombosis and Haemostasis, 88, 98 103.
15. Hoffman, M., Pratt, C.W., Corbin, L.W. Church, F.C. (1990) Characteristics of the chemotactic activity of heparin cofactor II proteolysis products. Journal of Leukocyte Biology, 48, 156 162.
16. Hoffman, M., Monroe, D.M. Roberts, H.R. (1992) A rapid method to isolate platelets from human blood by density gradient centrifugation. American Journal of Clinical Pathology, 98, 531 533.
17. Hoffman, M., Monroe, D.M., Oliver, J.A. Roberts, H.R. (1995) Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood, 86, 1794 1801.
18. Hu, H., Daleskog, M. Li, N. (2000) Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding. Thrombosis Research, 100, 161 166.
19. Jones, A.J. Meunier, A.M. (1990) A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thrombosis and Haemostasis, 64, 455 463.
20. Kjalke, M., Ezban, M., Monroe, D.M., Hoffman, M., Roberts, H.R. Hedner, U. (2001) High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. British Journal of Haematology, 114, 114 120.
21. Leiby, D.A., Kerr, K.L., Campos, J.M. Dodd, R.Y. (1997) A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion, 37, 259 263.
22. Levi, M., Friederich, P.W., Middleton, S., de Groot, P.G., Wu, Y.P., Harris, R., Biemond, B.J., Heijnen, H.F., Levin, J. ten Cate, J.W. (1999) Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nature Medicine, 5, 107 111.
23. Lindley, C.M., Sawyer, W.T., Macik, B.G., Lusher, J., Harrison, J.F., Baird-Cox, K., Birch, K., Glazer, S. Roberts, H.R. (1994) Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clinical Pharmacology and Therapeutics, 55, 638 648.
24. Livnat, T., Zivelin, A., Martinowitz, U., Salomon, O. Seligsohn, U. (2006) Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. Journal of Thrombosis and Haemostasis, 4, 192 200.
25. Miyazaki, Y., Nomura, S., Miyake, T., Kagawa, H., Kitada, C., Taniguchi, H., Komiyama, Y., Fujimura, Y., Ikeda, Y. Fukuhara, S. (1996) High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood, 88, 3456 3464.
26. Monroe, D.M., Hoffman, M., Oliver, J.A. Roberts, H.R. (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. British Journal of Haematology, 99, 542 547.
27. Read, M.S., Reddick, R.L., Bode, A.P., Bellinger, D.A., Nichols, T.C., Taylor, K., Smith, S.V., McMahon, D.K., Griggs, T.R. Brinkhous, K.M. (1995) Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proceedings of the National Academy of Sciences of the United States of America, 92, 397 401.
28. Saxena, K., Pethe, K. Dale, G.L. (2006) Coated-platelet levels may explain some variability in clinical phenotype of severe hemophilia. Blood (ASH Annual Meeting Abstracts), 108, 1018.
29. Schmidt, V., Hilberg, T., Franke, G., Glaser, D. Gabriel, H.H. (2003) Paraformaldehyde fixation induces a systematic activation of platelets. Platelets, 14, 287 294.
30. Slichter, S.J. Harker, L.A. (1976) Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. British Journal of Haematology, 34, 403 419.
31. Tonda, R., Galan, A.M., Mazzara, R., White, J.G., Ordinas, A. Escolar, G. (2004) Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia. Seminars in Hematology, 41, 157 162.
32. Valeri, C.R., MacGregor, H., Barnard, M.R., Summaria, L., Michelson, A.D. Ragno, G. (2005) Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sanguinis, 88, 122 129.
33. Wolberg, A.S., Gabriel, D.A. Hoffman, M. (2002) Analyzing fibrin clot structure using a microplate reader. Blood Coagulation and Fibrinolysis, 13, 533 539.
34. Wolberg, A.S., Monroe, D.M., Roberts, H.R. Hoffman, M. (2003) Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood, 101, 3008 3013.
35. Wolberg, A.S., Allen, G.A., Monroe, D.M., Hedner, U., Roberts, H.R. Hoffman, M. (2005) High dose factor VIIa improves clot structure and stability in a model of haemophilia B. British Journal of Haematology, 131, 645 655.
36. Wong, K., Li, X. Ma, Y. (2006) Paraformaldehyde induces elevation of intracellular calcium and phosphatidylserine externalization in platelets. Thrombosis Research, 117, 537 542.
37. Yang, X. Walsh, P.N. (2005) An ordered sequential mechanism for factor IX and factor IXa binding to platelet receptors in the assembly of the factor X-activating complex. Biochemical Journal, 390, 157 167.